NMPA Issued the Guiding Principles for Capacity Building of Drug Inspection and Testing Institutions

2019-08-30

NMPA has organized the formulation of and released on August 30,2019 the Guiding Principles for Capacity Building of Drug Inspection and Testing Institutions.

Newly Revised Drug Administration Law Adopted After Deliberation —To Comprehensively Implement the Four Strictest Requirements and Effectively Protect Drug Safety for the Public

2019-08-26

The remarkable results of pharmaceutical reforms and effective practices were transformed into laws to beef up rule of law for public health.

Announcement of the National Medical Products Administration, the Ministry of Public Security, and the National Health Commission, on the Inclusion of Varieties including Oxycodone-containing Medicines as Psychotropic Drugs

2019-08-13

Provisions for In-vitro Diagnostic Reagent Registration (Abolished)

2019-07-25

The Provisions for In-vitro Diagnostic Reagent Registration, adopted at the executive meeting of China Food and Drug Administration on June 27, 2014, is hereby promulgated and shall be effective as of October 1, 2014.

Provisions for Supervision of Drug Distribution

2019-07-25

The Provisions for Supervision of Drug Distribution, adopted at the executive meeting of the State Food and Drug Administration on December 8, 2006, is hereby promulgated and shall go into effect as of May 1, 2007.

Provisions for Drug Registration (Abolished)

2019-07-25

The Provisions are formulated for the purposes of ensuring the safety, efficacy and quality of drugs and regulating drug registration in accordance with the Drug Administration Law of the People's Republic of China, Administrative Permission Law of the People's Republic of China and the Regulations for Implementation of the Drug Administration Law of the People's Republic of China.